Facts and challenges of immunotherapy in triple-negative breast cancer

The role of pyroptosis-related genes in breast cancer progression

Immune modulation and epigenetic therapies for enhanced outcome of treatment in triple-negative breast cancer

Efficacy of pyrotinib and capecitabine in recurrent breast cancer with a HER2-negative genetic switch following systemic therapy: A case report and literature review

Cyclin-dependent kinase 4/6 inhibitor resistance mechanisms and strategies for subsequent treatment in breast cancer: A comprehensive review

Characterizing breast cancer in Myanmar: Insights from receptor status and tumor staging

Emerging immunomodulatory effects of CDK4/6 inhibitors in breast cancer therapy: A comprehensive review

Clinical advancements in breast cancer research: A comprehensive review

RIBC2 expression as a potential diagnostic and prognostic biomarker associated with tumor progression and immune modulation in breast cancer

Innovative index for quantifying breast cancer development through T₁- and T₂-weighted magnetic resonance imaging images